APA (7th ed.) Citation

Ingersoll, M. A., Lutze, R. D., Pushpan, C. K., Kelmann, R. G., Liu, H., May, M. T., . . . Teitz, T. (2023, December). Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model. JCI Insight.

Chicago Style (17th ed.) Citation

Ingersoll, Matthew A., Richard D. Lutze, Chithra K. Pushpan, Regina G. Kelmann, Huizhan Liu, Mark T. May, William J. Hunter, David Z.Z He, and Tal Teitz. "Dabrafenib Protects from Cisplatin-induced Hearing Loss in a Clinically Relevant Mouse Model." JCI Insight Dec. 2023.

MLA (9th ed.) Citation

Ingersoll, Matthew A., et al. "Dabrafenib Protects from Cisplatin-induced Hearing Loss in a Clinically Relevant Mouse Model." JCI Insight, Dec. 2023.